Moderate

Generalised lymphadenopathy — diagnostic approach (adult; also localised lymphadenopathy workup)

Diagnostic workup · Geriatric & General
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Enlarged lymph nodes in two or more non-contiguous regions (generalised) or in a single region (localised). Most cases are reactive/benign (infection), but the key task is to identify the minority due to malignancy (lymphoma, leukaemia, metastatic carcinoma) or serious infection (HIV, TB). Assessment is guided by node characteristics, associated symptoms, age and exposures; persistent, hard, fixed, matted or large nodes, and B symptoms, mandate prompt investigation and usually excisional biopsy.

Red flags

  • Supraclavicular node (high malignancy risk — Virchow's node, left; always investigate)
  • Hard, fixed, matted, or progressively enlarging nodes; node >2 cm persisting >3-4 weeks
  • B symptoms (fever, night sweats, weight loss), hepatosplenomegaly, pallor/bruising (leukaemia)
  • Associated pancytopenia or markedly raised LDH
  • Rapidly enlarging node with airway/SVC compression

Assessment

Differential diagnosis

  • Reactive/infective (commonest): viral (EBV/CMV, HIV seroconversion, hepatitis), bacterial (streptococcal, TB, syphilis, brucellosis, cat-scratch), parasitic (toxoplasmosis, leishmaniasis), fungal
  • Malignant: lymphoma (Hodgkin/non-Hodgkin), chronic/acute leukaemia, metastatic carcinoma (head & neck, breast, lung, GI — usually localised)
  • Autoimmune/inflammatory: SLE, rheumatoid arthritis, sarcoidosis, adult-onset Still's, Kikuchi disease, IgG4-related disease
  • Drugs (phenytoin, allopurinol, carbamazepine — DRESS), serum sickness
  • Endocrine/other: hyperthyroidism, Castleman disease, storage disease; in India/tropics think TB, HIV, leishmaniasis, filariasis

Investigations

  • Characterise nodes: site, size (>1 cm, >2 cm concerning), consistency (hard/rubbery), mobility (fixed/matted), tenderness, duration; examine ALL node groups + liver/spleen
  • Systemic clues: B symptoms (fever, drenching night sweats, >10% weight loss), pruritus, alcohol-induced node pain (Hodgkin), exposures, drugs, travel, sexual history
  • First-line bloods: FBC + blood film, ESR/CRP, LDH, U&E, LFTs, HIV test, monospot/EBV serology, consider toxoplasma/CMV serology
  • Further: TB testing (IGRA, CXR), autoimmune screen (ANA), syphilis serology as indicated
  • Imaging: USS of nodes (reactive vs suspicious architecture), CXR; CT neck/chest/abdomen/pelvis if lymphoma/malignancy suspected
  • TISSUE is key: excisional lymph node biopsy (preferred for lymphoma — preserves architecture) rather than fine-needle aspiration where lymphoma suspected; bone marrow if leukaemia/lymphoma

Management

  • Decide generalised vs localised, and whether features are benign or alarming
  • If clearly reactive (young, tender, mobile, recent infection, well): treat/observe and review in 2-4 weeks
  • Exclude and test for HIV and EBV/CMV early in generalised lymphadenopathy
  • If persistent (>3-4 weeks), enlarging, hard/fixed/matted, >2 cm, supraclavicular, with B symptoms or hepatosplenomegaly: investigate urgently
  • Arrange imaging and refer for excisional biopsy of the most abnormal/representative node (avoid FNA alone if lymphoma suspected)
  • Review drug history — stop culprit if drug-induced lymphadenopathy suspected
  • Refer on suspected-cancer pathway (2-week-wait) for unexplained persistent lymphadenopathy or splenomegaly
  • Treat the identified cause (antibiotics/antivirals for specific infection, oncology for malignancy, specialist for autoimmune)

Drugs & doses

No empirical treatment for undiagnosed lymphadenopathy — investigate first; avoid blind antibiotic courses
Treat specific infective cause once identified (e.g. appropriate antibiotics for bacterial lymphadenitis, anti-TB therapy for tuberculous nodes, per local protocol) [verify local]
Analgesia/antipyretic for symptomatic reactive nodes: paracetamol 1 g PO up to four times daily [verify local dose]
Avoid corticosteroids before a tissue diagnosis — they can mask/partially treat lymphoma and obscure histology

Disposition

Benign reactive: observe and review in 2-4 weeks. Persistent/alarming: urgent suspected-cancer referral, imaging and excisional biopsy. Admit if systemically unwell, marrow failure, or compressive complications.

Complications & pitfalls

  • Delayed diagnosis of lymphoma/leukaemia or metastatic carcinoma
  • Missed HIV or TB (both treatable and transmissible)
  • Complications of underlying disease (marrow failure, organ infiltration, SVC obstruction)

Exam pearls

  • Supraclavicular lymphadenopathy is malignant until proven otherwise — always image and biopsy.
  • For suspected lymphoma, excisional biopsy preserves nodal architecture; FNA alone is often inadequate.
  • Always test for HIV and EBV in unexplained generalised lymphadenopathy.
  • Do not give steroids before histology — they can partially treat lymphoma and ruin the diagnosis.
  • Reactive nodes are usually <1 cm, soft, mobile and tender; worry about hard, fixed, matted, large and persistent nodes.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.